Cancer
Filter By: News | Articles | Products | Posters | White Papers | Videos | Podcasts | Application Notes | Journal Articles
Molecule Tells Brain Cells to Grow Up, Get to Work
Mar 11 | News
Stanford University School of Medicine scientists have now identified a molecular master switch that catalyzes precursor cells’ transition to mature, myelin-making mavens. The results may have implications for medical treatment, as defects in this maturation process have been observed in both multiple sclerosis and the most common kind of brain cancers in adults, known as gliomas.
Synthetic Molecules Trigger Immune Response to HIV and Prostate Cancer
Nov 10 2009 | News
Researchers at Yale University have developed synthetic molecules capable of enhancing the body’s immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases.
Discovery In Worms Points to More Targeted Cancer Treatment
Nov 10 2009 | News
Researchers at Queen’s University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment.
Obama Says $5B in Grants Will Aid Medical Research
Oct 1 2009 | News
By Julie Pace, Asssociated Press Writer BETHESDA, Md. – Calling scientific research a job-creating engine, President Barack Obama heralded $5 billion in new government grants Wednesday to fight cancer, autism and heart disease while boosting the economy.
Use of Toad Venom in Cancer Treatment Examined
Sep 25 2009 | News
Huachansu, a Chinese medicine that comes from the dried venom secreted by the skin glands of toads, has tolerable toxicity levels, even at doses eight times those normally administered, and may slow disease progression in some cancer patients, say researchers from The University of Texas M. D.